Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
711 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018
712 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
 		Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2018
713 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Department of Radiology Dr. Mohamed Mahmoud Hamdy Abd Ellah Mohamed 2018
714 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018
715 Serum Immunoglobulin Paraprotein in Patients with Chronic Lymphocytic Leukemia Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2018
716 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
 		Department of Radiotherapy and Nuclear medicine Prof. Hamza Abbas Hamza Mohammed 2018
717 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2018
718 epidural dexmedetomidine infusion for
perioperative analgesia in patients undergoing
abdominal cancer surgery: randomized trial 		Department of Anesthesia, Intensive care and Pain management Prof. Khaled Mohamed Fares Ali 2018
719 The Contribution of NK Cells and CMV Infection in the Clinical Course of Pediatrics ALL Patients. Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2017
720 Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2017